Nitto Avecia
Kenji Nawa's work experience includes a role as the Sr. Director of New Life Science Business Development at Nitto Avecia starting in March 2021. Prior to that, they served as the Chairman of Infraredx, Inc. from May 2016 to March 2021. Before that, they held the position of President & CEO at Goodman, China from July 2014 to April 2016. Kenji also served as the General Manager of Global Business Development at Goodman Co., Ltd. from September 2010 to April 2016. Additionally, they worked as the Director of Sales and Marketing, Asia Pacific at LightLab Imaging, Inc. from April 2006 to August 2010.
Kenji Nawa's education history includes a Master of Business Administration (MBA) degree from Hitotsubashi ICS (Hitotsubashi University Business School), a Master of Medical Administration (MMA) degree from the Graduate School of Tokyo Medical and Dental University, and a Bachelor's degree in Commerce and Management from Hitotsubashi University.
This person is not in any teams
Nitto Avecia
1 followers
Oligonucleotides are giving rise to a new generation of therapeutics—and Nitto Avecia is helping lead the way. With more than 25 years’ experience in oligonucleotide development and production, we are the partner of choice for pharmaceutical innovators creating new drugs with the power to transform treatment for a wide range of diseases. In partnership with Nitto Avecia Pharma Services, Nitto Avecia is the first CMO that offers a comprehensive, end-to-end oligonucleotide solution. This offers the advantage of a single, expert partner handling the entire process—from drug substance through drug product manufacturing—with flexible solutions and consistent reliability and quality.